Developing a one-two punch cancer nanoparticle for resistant tumours | Paula T. Hammond

The most aggressive cancers have genetic mutations that enable them to survive our most powerful drugs. Paula T. Hammond, Head of the Department of Chemical Engineering at the Massachusetts Institute of Technology, explains the making of a nanoparticle that can kill a tumour by delivering both the drug and siRNA to block its drug-resisting genes. http://www.weforum.org/